Skip to main content
OpenTrials
Completed

NCT Number: NCT03369652

Telephone Contact Between Hospital and General Practitioner About Medication Review for Older Patients

In this trial, the feasibility of cooperation between clinical pharmacists and physicians by conducting a telephone follow-up conversation between the hospital geriatrician, the general practitioner and the clinical pharmacist is evaluated. During hospital stay the clinical pharmacist and the geriatrician will review older patients' medication and discuss the future treatment with the general practitioner after discharge by telephone or medico-technology.

The first part of the feasibility study will be a qualitative baseline measure of characteristics of the participants and work flow. The second part will be a pilot randomized controlled study where participants will be allocated to either usual care or medication review and follow up contact

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Older Patients Cross-sectional Communication Medication Review

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Odense University Hospital, Odense, Denmark

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 5 drugs or more

Exclusion criteria

  • Terminal illness
  • Not able to speak and understand Danish

Treatment and study plan

Medication review

Behavioral

Conducted by the pharmacist and discussed with hospital physician

Primary outcomes

  1. Changes in number of medications

    Time frame: At admission and at discharge

    Increase or decrease in number of medications from admission to discharge

  2. Parts of the intervention completed

    Time frame: Day 1 after discharge

    In the intervention Group only, it is measured, how many of the elements of the intervention the patient actually have received

  3. Changes in the Electronic Medication Profile (FMK)

    Time frame: 14 days after discharge

    How many changes have been Applied to the Electronic Medication Profile

Secondary outcomes

  1. Number of readmissions

    Time frame: within 30 days after discharge

    Data from registers

  2. Number of emergency visits

    Time frame: within 30 days after discharge

    Data from registers

  3. Number of visits at general practitioner

    Time frame: within 30 days after discharge

    Data from registers

  4. Patient satisfaction with the discharge

    Time frame: 14 days after discharge

    Measured by telephone interview

  5. Changes in patient-experienced quality of life

    Time frame: At admission and 14 days after discharge

    Measured by telephone interview using the 5-item questionnaire EQ-5D, where each question can be answered on a 5-point Likert Scale ranging from "very high degree of problems" to "very low degree of problems"

  6. Health care professionals satisfaction

    Time frame: 3 months after implementation

    Measured by a questionnaire

Sponsors and collaborators

Lead sponsor

Odense University Hospital

Other

Registry information

Official study title

Can Telephone Contact After Discharge Between Geriatrician, Clinical Pharmacist and General Practitioner About Medication Review in Hospital Improve the Medication in Older Patients? A Feasibility Study.

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Dec 12, 2017
Registry last updated
Mar 19, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.